Malaria vaccines to moderate the impact of antibiotic resistance in endemic countries

J Med Microbiol. 2023 Jul;72(7). doi: 10.1099/jmm.0.001734.ABSTRACTSwift and widespread deployment of an efficient malaria vaccine in Pakistan, together with basic control and preventive measures, could significantly decrease the economic and healthcare burden caused by drug-resistant malaria. Moreover, the RTS,S/AS01 vaccine has provided a much needed breakthrough after decades of growth, as an innovative vaccine for malaria in phase 3 clinical trials and currently undergoing implementation studies. Vaccination is a potentially critical component of efforts to arrest the development and dissemination of antimicrobial resistance, although little is known about the impact vaccination may have within low- and-middle-income countries.PMID:37493512 | DOI:10.1099/jmm.0.001734
Source: Journal of Medical Microbiology - Category: Microbiology Authors: Source Type: research